Evaluation of the Automated Phoenix System for Potential Routine Use in the Clinical Microbiology Laboratory

Journal of Clinical Microbiology

Volumn 42, Issue 4, 2004, Pages 1542-1546

  Donay, J L ^a   Mathieu, D ^b   Fernandes, P ^a   Pregermain C ^b   Bruel, P ^b   Wargnier, A ^a   Casin, I ^a   Weill, F X ^a   Lagrange, P H ^a   Herrmann, J L ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FUSIDIC ACID; GENTAMICIN; IMIPENEM; KANAMYCIN; LINCOMYCIN; OFLOXACIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ANALYTICAL EQUIPMENT; ANALYTICAL ERROR; ANTIBIOTIC SENSITIVITY; ARTICLE; ENTEROBACTERIACEAE; ENTEROCOCCUS; EVALUATION; GRAM NEGATIVE BACTERIUM; LABORATORY AUTOMATION; MICROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; AUTOMATION; BACTERIAL INFECTIONS; BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LABORATORIES; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGY; SENSITIVITY AND SPECIFICITY;

BACILLI; BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ENTEROCOCCUS; NEGIBACTERIA; PHOENIX; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 3943060127     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.4.1542-1546.2004     Document Type: Article

References (45)

1. Barry, J., A. Brown, V. Ensor, U. Lakhani, D. Petts, C. Warren, and T. Winstanley. 2003. Comparative evaluation of the VITEK 2 Advanced expert system (AES) in five UK hospitals. J. Antimicrob. Chemother. 51:1191-1202.
2. Bouvet, P. J. M., and P. A. D. Grimont. 1986. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov., and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffi. Int. J. Syst. Bacteriol. 36:228-240.
3. Brisse, S., S. Stefani, J. Verhoef, A. Van Belkum, P. Vandamme, and W. Goessens. 2002. Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J. Clin. Microbiol. 40:1743-1748.
4. Carret, C., J. D. Cavallo, H. Chardon, C. Chidiac, P. Choutet, P. Courvalin, H. Dabernat, H. Drugeon, L. Dubreuil, F. Goldstein, V. Jarlier, R. Leclercq, M. H. Nicolas-Chanoine, A. Philippon, C. Quentin, B. Rouveix, J. Sirot, and J. C. Soussy. 2003. Comite de l'Antibiogramme de la Societe Francaise de Microbiologie report 2003. Int. J. Antimicrob. Agents 21:364-391.
5. Cavallo, J. D., F. Leblanc, R. Fabre, A. Fourticq-Esqueöute, and the GERPB. 2001. Survey of the antibiotic sensitivity of Pseudomonas aeruginosa in France and the distribution of beta-lactam resistance mechanisms: the GERPB 1999 study. Pathol. Biol. 49:534-539.
6. Chavez, M., J. L. Garcia-Lopez, J. Coronilla, A. Valverde, M. C. Serrano, R. Claro, and E. Martin-Mazuelos. 2002. Evaluation of the new VITEK 2 system for determination of the susceptibility of clinical isolates of Streptococcus pneumoniae. Chemotherapy 48:26-30.
7. Dib, C., J. Trias, and V. Jarlier. 1995. Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactams in Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. 14:979-986.
8. Doern, G., R. Vautour, M. Gaudet, and B. Levy. 1994. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 32:1757-1762.
9. Endimiani, A., F. Luzzaro, A. Tamborini, G. Lombardi, V. Elia, R. Belloni, and A. Toniolo. 2002. Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix automated microbiology system. New Microbiol. 25:323-329.
10. Fahr, A. M., U. Eigner, M. Armbrust, A. Caganic, G. Dettori, C. Chezzi, L. Bertoncini, M. Benecchi, and M. G. Menozzi. 2003. Two-center collaborative evaluation of the performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterococcus spp. and Staphylococcus spp. J. Clin. Microbiol. 41:1135-1142.
11. Felten, A., B. Grandry, P. H. Lagrange, and I. Casin. 2002. Evaluation of three techniques for detection of low-level methicillin-resistant Stapkylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J. Clin. Microbiol. 40:2766-2771.
12. Ferraro, M. J., and J. H. Jorgensen. 1995. Instrument-based antibacterial susceptibility testing, p. 1375-1384. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
13. Freeman, J. W., R. W. Rowland, S. B. Overman, and N. L. Goodman. 1981. Laboratory evaluation of the AutoMicrobic system for identification of Enterobacteriaceae. J. Clin. Microbiol. 13:895-898.
14. Funke, G., C. Monnet, C. de Bernardis, A. von Graevenitz, and J. Freney. 1998. Evaluation of the Vitek 2 system for rapid identification of medically relevant rods. J. Clin. Microbiol. 36:1948-1952.
15. Garcia-Garrote, F., E. Cercenado, and E. Bouza. 2000. Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J. Clin. Microbiol. 38:2108-2111.
16. Hasyn, J. J., K. R. Cundy, C. C. Dietz, and W. Wong. 1981. Clinical laboratory evaluation of the Auto-Microbic system for rapid identification of Enterobacteriaceae. J. Clin. Microbiol. 13:491-497.
17. Johnson, J. E., J. H. Jorgensen, S. A. Crawford, J. S. Redding, and R. C. Pruneda. 1983. Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli. J. Clin. Microbiol. 18:1301-1309.
18. Jossart, M. F., and R. J. Courcol. 1999. Evaluation of an automated system for identification of Enterobacteriaceae and nonfermenting bacilli. Eur. J. Clin. Microbiol. Infect. Dis. 18:902-907.
19. Joyanes, P., M. del Carmen Conejo, L. Martínez-Martínez, and E. J. Perea. 2001. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J. Clin. Microbiol. 39:3247-3253.
20. Kazmierczak, A., X. Cordin, J. M. Duez, E. Siebor, A. Pechinot, and J. Sirot. 1990. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria. J. Int. Med. Res. 18:67-77.
21. Kitzis, M. D., B. Ferre, A. Coutrot, J. F. Acar, and L. Gutman. 1989. In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 8:783-788.
22. Leclercq, R., M. H. Nicolas-Chanoine, P. Nordmann, A. Philippon, P. Marchais, A. Buu-Hoi, H. Chardon, H. Dabernat, F. Doucet-Populaire, C. Grasmick, P. Legrand, C. Muller-Serieys, J. Nguyen, M. C. Ploy, M. E. Reverdy, M. Weber, and R. J. Courcol. 2001. Multicenter evaluation of an automated system using selected bacteria that harbor challenging and clinically relevant mechanisms of resistance to antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 20:626-635.
23. Leverstein-van Hall, M. A., A. C. Fluit, A. Paauw, A. T. Box, S. Brisse, and J. Verhoef. 2002. Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 40:3703-3711.
24. Ligozzi, M., C. Bernini, M. Grazia Bonora, M. de Fatima, J. Zuliani, and R. Fontana. 2002. Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. J. Clin. Microbiol. 40:1681-1686.
25. Ling, T. K., P. C. Tam, Z. K. Liu, and A. F. Cheng. 2001. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J. Clin. Microbiol. 39:2964-2966.
26. Livermore, D. M. 1992. Interplay of impermeability and chromosomal beta-lactamase in imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:2046-2048.
27. McGregor, A., F. Schio, S. Beaton, V. Boulton, M. Perman, and G. Gilbert. 1995. The MicroScan WalkAway diagnostic microbiology system: an evaluation. Pathology 27:172-176.
28. Moosdeen, F., J. Keeble, and J. D. Williams. 1986. Induction / inhibition of chromosomal beta-lactamase inhibitors. Rev. Infect. Dis. 8:S562-S568.
29. Nadjar, D., M. Rouveau, C. Verdet, J. L. Donay, J. L. Herrmann, P. H. Lagrange, A. Philippon, and G. Arlet. 2000. Outbreak of Klebsiella pneumoniae producing transferable AmpC-type β-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol. Lett. 187:35-40.
30. Nikaido, H. 1998. Multiple antibiotic resistance and efflux. Curr. Opin. Microbiol. 1:516-523.
31. O'Hara, C. M., and J. M. Miller. 2003. Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family Enterobacteriaceae and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ card. J. Clin. Microbiol. 41:2096-2101.
32. Pfaller, M. A., and L. A. Herwaldt. 1988. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin. Microbiol. Rev. 1:281-299.
33. Pfaller, M. A., D. Sahm, C. O'Hara, C. Ciaglia, M. Yu, N. Yamane, G. Scharnweber, and D. Rhoden. 1991. Comparison of the autoSCAN-W/A rapid bacterial identification system and the Vitek AutoMicrobic system for identification of gram-negative bacilli. J. Clin. Microbiol. 29:1422-1428.
34. Poole, K. 2000. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob. Agents Chemother. 44:2233-2241.
35. Rhoads, S., L. Marinelli, C. A. Imperatrice, and I. Nachamkin. 1995. Comparison of MicroScan WalkAway system and Vitek system for identification of gram-negative bacteria. J. Clin. Microbiol. 33:3044-3046.
36. Sanders, C. C., M. Peyret, E. Smith Moland, S. J. Cavalieri, C. Shubert, K. S. Thomson, J. M. Boeufgras, and W. E. Sanders, Jr. 2001. Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital. J. Clin. Microbiol. 39:2379-2385.
37. Sanguinetti, M., B. Posteraro, T. Spanu, D. Ciccaglione, L. Romano, B. Fiori, G. Nicoletti, S. Zanetti, and G. Fadda. 2003. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum β-lactamase detection method. J. Clin. Microbiol. 41:1463-1468.
38. Stager, C. E., and J. R. Davies. 1992. Automated systems for identification of microorganisms. Clin. Microbiol. Rev. 5:302-327.
39. Tenover, F. C., T. S. Mizuki, and L. G. Carlson. 1990. Evaluation of auto-SCAN-W/A automated microbiology system for the identification of non-glucose-fermenting gram-negative bacilli. J. Clin. Microbiol. 28:1628-1634.
40. Thornsberry, C., J. P. Anhalt, J. A. Washington 2nd, L. R. McCarthy, F. D. Schoenknecht, J. C. Sherris, and H. J. Spencer. 1980. Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study. J. Clin. Microbiol. 12:375-390.
41. Thornsberry, C. 1985. Automated procedures for antimicrobial susceptibility tests, p. 1015-1018. In E. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Sadomy (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
42. van Den Braak, N., W. Goessens, A. van Belkum, H. A. Verbrugh, and H. P. Endtz. 2001. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci. J. Clin. Microbiol. 39:351-353.
43. Woolfrey, B. F., R. T. Lally, and C. O. Quall. 1983. Evaluation of the AutoSCAN-3 and Sceptor systems for Enterobacteriaceae identification. J. Clin. Microbiol. 17:807-813.
44. Yamazumi, T., S. A. Marshall, W. W. Wilke, D. J. Diekema, M. A. Pfaller, and R. N. Jones. 2001. Comparison of the Vitek gram-positive susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus. J. Clin. Microbiol. 39:53-56.
45. Yamazumi, T., I. Furuta, D. J. Diekema, M. A. Pfaller, and R. N. Jones. 2001. Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci. J. Clin. Microbiol. 39:3633-3636.